✦ LIBER ✦

Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer

✍ Scribed by James P. Stevenson; Corey J. Langer; Robert A. Somer; Tracey L. Evans; Kumar Rajagopalan; Kimberly Krieger; Mona Jacobs-Small; Nikolas Dyanick; Barry Milcarek; Susan Coakley; Suzanne Walker; Beth Eaby-Sandy; Alexandre Hageboutros

Book ID: 112067182
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 939 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27576

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Bevacizumab plus Pemet

Phase II Trial of Bevacizumab plus Pemetrexed and Carboplatin in Previously Untreated Advanced Nonsquamous Non–Small-Cell Lung Cancer

✍ C. Dalsania; A. Hageboutros; E. Harris; K. Krieger; C. Vora; J.P. Stevenson 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB

PointBreak: A Randomized Phase III Study

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer

✍ Patel, J. D.; Socinski, M. A.; Garon, E. B.; Reynolds, C. H.; Spigel, D. R.; Ols 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 243 KB

Treatment Rationale and Study Design for

Treatment Rationale and Study Design for a Randomized Trial of Pemetrexed/Carboplatin Followed by Maintenance Pemetrexed Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced Non–Small-Cell Lung Cancer of Nonsquamous Histology

✍ Ralph G. Zinner; Scott B. Saxman; Guangbin Peng; Matthew J. Monberg; Waldo I. Or 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 122 KB

Randomized Phase III Trial of Maintenanc

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)

✍ Barlesi, F.; Scherpereel, A.; Rittmeyer, A.; Pazzola, A.; Ferrer Tur, N.; Kim, J 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 188 KB

Phase 2 study of S-1 and carboplatin plu

Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer

✍ Urata, Yoshiko; Okamoto, Isamu; Takeda, Masayuki; Hattori, Yoshihiro; Okuno, Kei 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A Phase II Trial of First-line Bevacizum

A Phase II Trial of First-line Bevacizumab in Combination With Pemetrexed and Carboplatin in Advanced Nonsquamous Non–Small-Cell Lung Cancer: Preliminary Results

✍ Z. Skaff; A. Hageboutros; K. Krieger; S. Coakley; R. Somer; J. Stevenson 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 43 KB